| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |